Ardelyx Inc (ARDX)
5.29
-0.03
(-0.56%)
USD |
NASDAQ |
Jul 05, 16:00
5.26
-0.03
(-0.57%)
After-Hours: 20:00
Ardelyx Revenue (Annual): 124.46M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 124.46M |
| December 31, 2022 | 52.16M |
| December 31, 2021 | 10.10M |
| December 31, 2020 | 7.571M |
| December 31, 2019 | 5.281M |
| December 31, 2018 | 2.607M |
| Date | Value |
|---|---|
| December 31, 2017 | 42.00M |
| December 31, 2016 | |
| December 31, 2015 | 24.03M |
| December 31, 2014 | 31.62M |
| December 31, 2013 | 28.93M |
| December 31, 2012 | 5.41M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
5.281M
Minimum
2019
124.46M
Maximum
2023
39.91M
Average
10.10M
Median
2021
Revenue (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | 1.828B |
| Cytokinetics Inc | 7.53M |
| Amicus Therapeutics Inc | 399.36M |
| Insmed Inc | 305.21M |
| Rigel Pharmaceuticals Inc | 116.88M |